High Court Rejects Mylan Appeal Of Takeda Atty Fees
The U.S. Supreme Court has declined to hear Mylan Laboratories Inc.'s appeal of a decision awarding Takeda Pharmaceutical Co. Ltd. $16.8 million in attorneys' fees in a patent dispute over the...To view the full article, register now.
Already a subscriber? Click here to view full article